참고문헌
- Firestein GS, Zvaifler NJ. Rheumatoid Arthritis: A Disease of Disordered Immunity. New York: Raven Press; 1992.
- Aho K, HeliOvaara M, Maatela J, Tuomi T, Palosuo T: Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 18;1282-1284, 1991.
- Cush JJ: Early rheumatoid arthritis - is there a window of opportunity? J Rheumatol (Suppl) 80;1-7, 2007.
- Durie FH, Fava RA, Noelle RJ: Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol 73;11-18, 1994. https://doi.org/10.1006/clin.1994.1164
- Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, Mattsson R, Holmdahl R: Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 24;1698-1702, 1994. https://doi.org/10.1002/eji.1830240736
- Stuart JM, Townes AS, Kang AH: Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 69;673-683, 1982. https://doi.org/10.1172/JCI110495
- Wooley PH, Luthra HS, Stuart JM, David CS: Type II collagen- induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154;688-700, 1981. https://doi.org/10.1084/jem.154.3.688
- Myers LK, Rosloniec EF, Cremer MA, Kang AH: Collagen-induced arthritis, an animal model of autoimmunity. Life Sci 61;1861-1878, 1997. https://doi.org/10.1016/S0024-3205(97)00480-3
- Thornton S, Sowders D, Aronow B, Witte DP, Brunner HI, Giannini EH, Hirsch R: DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 105;155-168, 2002. https://doi.org/10.1006/clim.2002.5227
- Choy EH: Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. Clin Exp Rheumatol 27;510-518, 2009.
- Fournier C: Where do T cells stand in rheumatoid arthritis? Joint Bone Spine 72;527-532, 2005. https://doi.org/10.1016/j.jbspin.2004.12.012
- Mandik-Nayak L, Allen PM: Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis. Immunol Res 32;5-13, 2005. https://doi.org/10.1385/IR:32:1-3:005
- Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S: Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426;454-460, 2003. https://doi.org/10.1038/nature02119
- Nandakumar KS, Svensson L, Holmdahl R: Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 163;1827-1837, 2003. https://doi.org/10.1016/S0002-9440(10)63542-0
- Ciszak L, Pawlak E, Kosmaczewska A, Potoczek S, Frydecka I: Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases. Arch Immunol Ther Exp (Warsz) 55;373-386, 2007. https://doi.org/10.1007/s00005-007-0042-6
- Call ME, Wucherpfennig KW: Molecular mechanisms for the assembly of the T cell receptor-CD3 complex. Mol Immunol 40;1295-1305, 2004.
- Kuhns MS, Davis MM, Garcia KC: Deconstructing the form and function of the TCR/CD3 complex. Immunity 24;133-139, 2006. https://doi.org/10.1016/j.immuni.2006.01.006
- Miceli MC, Parnes JR: The roles of CD4 and CD8 in T cell activation. Semin Immunol 3;133-141, 1991.
- Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14;397-440, 1996. https://doi.org/10.1146/annurev.immunol.14.1.397
- Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P: Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354;1932-1939, 1999. https://doi.org/10.1016/S0140-6736(99)05246-0
- Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337;141-147, 1997. https://doi.org/10.1056/NEJM199707173370301
- Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group: Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343;1594-1602, 2000. https://doi.org/10.1056/NEJM200011303432202
- Booth G, Newham P, Barlow R, Raines S, Zheng B, Han S: Gene expression profiles at different stages of collagen- induced arthritis. Autoimmunity 41;512-521, 2008. https://doi.org/10.1080/08916930802095210
- Calin A, Elswood J, Klouda PT: Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. Arthritis Rheum 32;1221-1225, 1989. https://doi.org/10.1002/anr.1780321006
- Winchester R: The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 56;389-466, 1994.
- Van Boxel JA, Paget SA: Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 293;517-520, 1975. https://doi.org/10.1056/NEJM197509112931101
- Kraan MC, Smeets TJ, van Loon MJ, Breedveld FC, Dijkmans BA, Tak PP: Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis. Ann Rheum Dis 63;1056-1061, 2004. https://doi.org/10.1136/ard.2003.014738
- Berthelot JM, le Goff B, Maugars Y: Thymic Hassall's corpuscles, regulatory T-cells, and rheumatoid arthritis. Semin Arthritis Rheum 39;347-355, 2010. https://doi.org/10.1016/j.semarthrit.2008.08.010
- Kiessling R, Kono K, Petersson M, Wasserman K: Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules. Springer Semin Immunopathol 18;227-242, 1996. https://doi.org/10.1007/BF00820668
- Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, Bukowski RM, Ochoa AC: Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53;5613- 5616, 1993.
- Maurice MM, Lankester AC, Bezemer AC, Geertsma MF, Tak PP, Breedveld FC, van Lier RA, Verweij CL: Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol 159;2973-2978, 1997.
- Matsuda M, Ulfgren AK, Lenkei R, Petersson M, Ochoa AC, Lindblad S, Andersson P, Klareskog L, Kiessling R: Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol 47;254-262, 1998. https://doi.org/10.1046/j.1365-3083.1998.00296.x
- Trimble LA, Lieberman J: Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 91;585-594, 1998.
- Berg L, Ronnelid J, Klareskog L, Bucht A: Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness. Clin Exp Immunol 120;174-182, 2000. https://doi.org/10.1046/j.1365-2249.2000.01180.x
- Tartour E, Latour S, Mathiot C, Thiounn N, Mosseri V, Joyeux I, D'Enghien CD, Lee R, Debre B, Fridman WH: Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 63;205-212, 1995. https://doi.org/10.1002/ijc.2910630210
- de Vries JE, Yssel H, Spits H: Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes. Immunol Rev 109;119-141, 1989. https://doi.org/10.1111/j.1600-065X.1989.tb00022.x